FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

511000001103: Largactil 25mg tablets (Hawgreen Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16150901000001118 Largactil 25mg tablets (Hawgreen Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
66012001000001111 Largactil 25mg tablets (Sanofi) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Largactil 25mg tablets (Hawgreen Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Largactil 25mg tablets (Hawgreen Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Largactil 25mg tablets (Hawgreen Ltd) Is a Product containing precisely chlorpromazine hydrochloride 25 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Largactil 25mg tablets (Hawgreen Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Largactil 25mg tablets (Hawgreen Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Largactil 25mg tablets (Hawgreen Ltd) Has active ingredient Chlorpromazine hydrochloride false Inferred relationship Existential restriction modifier
Largactil 25mg tablets (Hawgreen Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Largactil 25mg tablets (Hawgreen Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Largactil 25mg tablets (Hawgreen Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Largactil 25mg tablets (Hawgreen Ltd) Is a Largactil true Inferred relationship Existential restriction modifier
Largactil 25mg tablets (Hawgreen Ltd) Has specific active ingredient Chlorpromazine hydrochloride true Inferred relationship Existential restriction modifier
Largactil 25mg tablets (Hawgreen Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Largactil 25mg tablets (Hawgreen Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Largactil 25mg tablets (Hawgreen Ltd) 56 tablet 2 x 28 tablets Is pack of False Largactil 25mg tablets (Hawgreen Ltd) Inferred relationship Existential restriction modifier
Largactil 25mg tablets (Hawgreen Ltd) 56 tablet 2 x 28 tablets Has AMP True Largactil 25mg tablets (Hawgreen Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start